Home LiteratureArticle Details
PMID: 16091205 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

WHIM syndrome: a defect in CXCR4 signaling.

Current allergy and asthma reports ·Vol. 5 ·No. 5 ·2005-09-00 ·Pages 350-5

Diaz GA, Gulino AV

Abstract

The study of inherited immunodeficiencies has proven valuable in elucidating molecular signaling cascades underlying the developmental and functional regulation of the human immune system. The first example of a human immunologic disease caused by mutation of a chemokine receptor was provided by WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome, a rare, combined immunodeficiency featuring an unusual form of neutropenia. Subsequent studies following the initial description of mutations in the CXCR4 gene have revealed a striking concordance in the types of mutations observed, suggesting that impaired regulation of receptor signaling by truncation of the cytoplasmic tail domain is an essential aspect in disease pathogenesis. Biochemical studies have provided support for the model that impaired receptor downregulation leads to the characteristic immunologic and hematologic disturbances. Interestingly, these genetic studies have also identified phenocopies with the same clinical features but without mutation of CXCR4, suggesting that mutations in as yet uncharacterized downstream regulators of the receptor may be involved in a proportion of cases.

MeSH Terms
Agammaglobulinemia/metabolism Humans Infections/metabolism Neutropenia/metabolism Receptors, CXCR4/metabolism Signal Transduction Syndrome Warts/metabolism
Chemicals
Receptors, CXCR4
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Diaz George A
Department of Human Genetics, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1498, New York, NY 10029, USA. george.diaz@mssm.edu
Gulino A Virginia
References (39)
39 references, click to expand
  1. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
    Science. 1996 Sep 27;273(5283):1856-62 PMID: 8791590
  2. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.
    Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9448-53 PMID: 9689100
  3. Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Br J Haematol. 1992 Feb;80(2):254-6 PMID: 1550786
  4. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
    Nature. 1996 Aug 22;382(6593):722-5 PMID: 8751444
  5. B-cell lymphoma in a patient with WHIM syndrome.
    J Am Acad Dermatol. 2001 Jan;44(1):124-8 PMID: 11148489
  6. Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature.
    J Pediatr Hematol Oncol. 1997 Sep-Oct;19(5):443-8 PMID: 9329467
  7. Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4.
    J Biol Chem. 2002 May 3;277(18):15677-89 PMID: 11867624
  8. A variant of myelokathexis with hypogammaglobulinemia: lymphocytes as well as neutrophils may reverse in response to infections.
    Pediatr Hematol Oncol. 2000 Mar;17(2):171-6 PMID: 10734660
  9. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis.
    Cancer Res. 1979 Mar;39(3):1074-82 PMID: 218721
  10. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization.
    J Biol Chem. 1999 Oct 22;274(43):31076-86 PMID: 10521508
  11. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia.
    Am J Med. 1990 Nov;89(5):663-72 PMID: 2239986
  12. 'Myelokathexis'. Neutropenia with marrow hyperplasia.
    Am J Dis Child. 1977 Jun;131(6):655-8 PMID: 868817
  13. Myelokathexis associated with multiple congenital malformations: immunological study on phagocytic cells and lymphocytes.
    Eur J Haematol. 1988 Jan;40(1):12-7 PMID: 3342858
  14. Identification of a major co-receptor for primary isolates of HIV-1.
    Nature. 1996 Jun 20;381(6584):661-6 PMID: 8649511
  15. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies.
    Am J Med Genet. 2000 Apr 24;91(5):368-76 PMID: 10767001
  16. Chemokines and disease.
    Nat Immunol. 2001 Feb;2(2):108-15 PMID: 11175802
  17. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.
    Immunity. 1999 Apr;10(4):463-71 PMID: 10229189
  18. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
    Nat Immunol. 2002 Jul;3(7):687-94 PMID: 12068293
  19. Dizygotic twin sisters with myelokathexis: mechanism of its neutropenia.
    Am J Hematol. 1999 Oct;62(2):106-11 PMID: 10509006
  20. Myelokathexis: chronic neutropenia with hyperplastic bone marrow and hypersegmented neutrophils in two siblings.
    Blut. 1981 Mar;42(3):191-6 PMID: 7214030
  21. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.
    Blood. 2000 Jan 1;95(1):320-7 PMID: 10607719
  22. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.
    Blood. 2004 Jul 15;104(2):565-71 PMID: 15054039
  23. An unusual form of chronic neutropenia in a father and daughter with hypogammaglobulinaemia.
    Br J Haematol. 1977 Jul;36(3):313-22 PMID: 889707
  24. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
    Nat Genet. 2003 May;34(1):70-4 PMID: 12692554
  25. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4.
    J Cell Biol. 1997 Nov 3;139(3):651-64 PMID: 9348282
  26. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization.
    J Biol Chem. 1997 Nov 7;272(45):28726-31 PMID: 9353342
  27. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.
    Nature. 1998 Jun 11;393(6685):595-9 PMID: 9634238
  28. Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis.
    J Pediatr. 1991 Feb;118(2):229-34 PMID: 1704431
  29. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.
    Immunity. 2003 Oct;19(4):583-93 PMID: 14563322
  30. A case of immunodeficiency characterized by neutropenia, hypogammaglobulinaemia, recurrent infections and warts.
    Clin Lab Haematol. 1994 Sep;16(3):297-302 PMID: 7828418
  31. Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis.
    Ann Hematol. 2002 Aug;81(8):470-3 PMID: 12224006
  32. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
    Nature. 1996 Aug 15;382(6592):635-8 PMID: 8757135
  33. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Pflugers Arch. 2000;440(5 Suppl):R81-2 PMID: 11005621
  34. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  35. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
    Blood. 2005 Mar 15;105(6):2449-57 PMID: 15536153
  36. "MYELOKATHEXIS"--A NEW FORM OF CHRONIC GRANULOCYTOPENIA. REPORT OF A CASE.
    N Engl J Med. 1964 Apr 2;270:699-704 PMID: 14101065
  37. Neutrophil-releasing activity of recombinant human granulocyte-macrophage colony stimulating factor in myelokathexis.
    Br J Haematol. 1992 Sep;82(1):169-70 PMID: 1419790
  38. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.
    Ann Intern Med. 1989 Dec 1;111(11):887-92 PMID: 2683920
  39. Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF.
    JAMA. 1992 Apr 22-29;267(16):2179-80 PMID: 1556785
Article Info
Journal
Current allergy and asthma reports
Abbr.
Curr Allergy Asthma Rep
ISSN
1529-7322
Published
2005-09-00
Pages
350-5
Language
English
Region
United States
NLM ID
101096440
Subset
IM
Grants
NIAID NIH HHS · P01 AI 61093 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com